Sun Pharmaceutical Industries Q1FY22 consolidated PAT soars to Rs. 1408.65 Cr

Sun Pharmaceutical Industries Q1FY22 consolidated PAT soars to Rs. 1408.65 Cr

By: ICN Bureau

Last updated : January 27, 2022 5:49 pm



It posted net loss of Rs.(2429.81) crores for the period ended June 30, 2020.


Sun Pharmaceutical Industries has reported total income of Rs.9871.26 crores during the period ended June 30, 2021 as compared to Rs.8633.98 crores during the period ended March 31, 2021.

The company reported total income Rs.7739.04 crores during the period ended June 30, 2020.

The company has posted net profit of Rs.1408.65 crores for the period ended June 30, 2021 as against net profit of Rs.848 crores for the period ended March 31, 2021.

It posted net loss of Rs.(2429.81) crores for the period ended June 30, 2020.

Sun Pharmaceutical Industries

First Published : July 31, 2021 12:00 am